Acrodermati ti s enteropathica is rare congenital autosomal recessive disorder. Premature are parti cularly risk and disease is caused by zinc defi ciency due to a specifi c absorpti ve defect. This disease manifests in child as peevish, withdrawn and photophobia and develop vesicobullous dermati ti s on hands, feet and periorofi cial areas and alopecia. Diarrhea is oft en present. This also presents as shunted growth and decrease resistance to infecti on. Poor wound healing.A low plasma zinc level and Serum alkaline phospahtase are useful indicator of zinc status.
INTRODUCTION
Acrodermati ti s enteropathica is the rare autosomal recessive disorder with prevalence of 1:500000. Premature are parti cularly at risk as this disease is caused by zinc defi ciency due to a specifi c absorpti ve defect. Although the cause of absorpti ve defect is unknown, the geneti c defect has been mapped to 8q24 and the defecti ve gene identi fi ed as SLC39A4, which encodes the zinc transporter Zip4. The disease typically starts aft er weaning or earlier if the infant is not given breast milk. However, clinical zinc defi ciency may occur in full term and premature infants sti ll breastf eeding. Usually, Acrodermati ti s Enteropathica (AE) presents soon aft er fourth to tenth week of life in infants who are not breast fed. The classic featrues of AE include alopecia, diarrhea, lethargy and an acute eczematous and erosive dermati ti s favoring acral areas-perioral, periocula, anogenital, hands and feet. The cutaneous fi ndings are highly characteristi c and oft en present initi ally as a non specifi c acrally distributed, symmetric, eczematous dermati ti s, over ti me, bullae and erosions with a characteristi c peripheral crusted border develop. Pati ents also appear to be predisposed to systemic infecti ons as a result of impaired cell mediated. Delayed wound healing, acute paronychia, conjuncti viti , bleephariti s and photophobia may also be observed. Diarrhea may be prominent but is not seen in all cases. If untreated, the disease is fatal. A low plasma zinc level is the gold standard for diagnosing zinc defi ciency. Serum alkaline phospahtase, a zinc dependent enzyme is another useful indicator of zinc status, as AP may be low even when plasma zinc levels are low normal, serum AP will increase with zinc supplementati on, thus confi rming the diagnosis. Patents with AE require lifelong treatment with zinc 1, 2, 3 .
CASE REPORT
A 7 years boy presented with erythematous scaly lesion in perioral, fi ngers, hands and perianal region. The lesions started since the child was 11 months and gradually increased in size, and the new lesion was noted on knee, foot and around anal area, in course of ti me there was involvement around mouth. Similarly there was gradual loss of hair in the scalp with photophobia. The lesion was occasionally pruriti c. Pati ent underwent treatment at various centers and various drugs were used, mostly moderate to potent topical steroid and salicylic acid. Although the vitamin syrup containing iron and zinc gave the best treatment response, this treatment was not conti nued for a long ti me. Although no abnormal perinatal history was noted, parents noted the growth was slow in comparision to other children of similar age group. On examinati on pati ent is irritable and restless. On skin examinati on there was erythematous scaly plaque with ill defi ned margin at hand, face, abdomen, periocular and perianal areas, multi ple erosion and ulcer with crusts noted at the plaque. Sparse fi ne hair at scalp. There were no nails changes, and other systemic examinati ons were normal. The laboratory investi gati on showed low plasma zinc and serum alkaline phosphatase level. Skin biopsy revealed hyperkeratosis, confl uent parakeratosis, spongiosis and focal dyskeratosis. Pati ent showed dramati c improvement aft er intake of zinc 10mg bid.
DISCUSSION
Acrodermati ti s enteropathica is a rare autosomal recessive disorder of zinc defi ciency. Although a defi ciency dermati ti s caused by low dietary zinc has the exact clinical and histologic features of AE, the term AE should be reserved only for geneti c causes of zinc defi ciency. In humans AE, fi rst described by Danbolt and Closs in 1943 4 , is the only known hereditary defect of zinc metabolism. Individuals with AE suff er from severe zinc defi ciency derived from a defecti ve uptake of zinc in the duodenum and jejunum 5 . AE usually presents in infancy within days if an infant is bott le-fed and soon aft er weaning in infants breast-fed, such as our pati ent. Several studies have tried to explain this well characterized diff erence 6, 7, 8 and as of yet there is no consensus. Initi ally, the cause of AE was unknown and the disease was oft en fatal. The link between zinc defi ciency and human pathology was not realized unti l 30 years aft er the initi al clinical descripti on of AE 9, 10, 11 . Homozygosity mapping of consanguineous Jordanian and Egypti an kindreds with AE localized the geneti c defect to 8q24 12 . Soon thereaft er the defecti ve gene was identi fi ed as SLC39A4 13, 14 , which encodes a ZIP protein, ZIP4.
Characteristi c lesions of AE and acquired defi ciency dermati ti s caused by low zinc include dry scaly eczematous plaques of the face, scalp and anogenital area, as well as generalized alopecia; none of which were present at our pati ent's initi al clinic visit. Establishing a diagnosis of zinc defi ciency may be further complicated by the fact that, zinc levels may fall during states of infl ammati on. The mechanism for this has not been enti rely elucidated but recently IL-6 has been shown to upregulate the Zinc transporter Zip14.
Histopathologic and laboratory studies are helpful but cannot defi niti vely make a diagnosis of zinc defi ciency. For AE, zinc replacement therapy should be started at 3 mg/kg/day of elemental zinc (there is 50 mg of elemental zinc per 220 mg zinc sulfate). Serum zinc levels should be monitored and the dose of zinc sulfate should be adjusted appropriately. Pati ents may require a higher dose than 3mg/kg/day of zinc sulfate to normalize their geneti c defect of zinc metabolism. In defi ciency dermati ti s caused by low dietary zinc, replacement therapy should be initi ated at 1mg/kg/day of elemental zinc. Maverakis E, 2007 found in the department of dermatology of University of California at age 13, large well-defi ned and confl uent erythematous plaques with grey to white scale over the extremiti es with lesions on periorally and perinasally. There was distal onycholysis of her toenails serum zinc level was 36 μg/dl (nl. 66-144 μg/dl). With zinc supplement her skin lesions almost enti rely resolved within 1 month 15 . Similarly, Shafi M, 1973 found fi ft een cases of acrodermati ti s enteropathica reported from S M H S Hospital Srinagar. There were 8 males and 7 females. The criterion of diagnosis of this conditi on was the clinical picture of symmetrical vesiculo-pustular dermati ti s, in upper and lower limbs and periorifi cial regions. Thirteen cases had variable degrees of diarrhoea, 10 were having glossiti s and stomati ti s, while 4 had conjuncti viti s, blephariti s and chronic paronychia. These children had low body weight, were apatheti c and irritable 16 .
CONCLUSION
Acrodermati ti s enteropathica is a rare autosomal recessive disorder of zinc defi ciency. The geneti c defect has been mapped to 8q24 and the defecti ve gene identi fi ed as SLC39A4, which encodes the zinc transporter Zip4. The diagnosis is made by way of clinical presentati on together with histopathology and laboratory tests. Life long zinc therapy is required to reduce the symptoms and signs of disease.
